SCHEMBL20193264

SCHEMBL20193264

CC(C)(O)C#Cc1cc2c(-c3cnn(COCCS(C)(C)C)c3)cn(S(=O)(=O)Cc3ccccc3)c2cn1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CHUK O15111 20/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16608428 0.91 CHUK (0.49) CHUK
SCHEMBL20193240 0.88 CHUK (0.61) CHUK
SCHEMBL20193200 0.88 CHUK (0.64) CHUK
SCHEMBL20193158 0.87 CHUK (0.50) CHUK
SCHEMBL20193233 0.84 CHUK (0.49) CHUK
SCHEMBL20193251 0.84 CREBBP (0.33)
SCHEMBL20193167 0.83 CHUK (0.57) CHUK
SCHEMBL20193241 0.83 CHUK (0.61) CHUK
SCHEMBL19114166 0.81 CHUK (0.59) CHUK
SCHEMBL20193185 0.81 CHUK (0.63) CHUK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9981963-B2 3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors JANSSEN PHARMACEUTICA NV (BE) 2018-05-29 US disclosed